(1)
K. Fakree, N.; H. Ali, S. Effect of COX-2 Inhibitors Selectivity on Lipid Profile in Hyperlipidemic and Normolipidemic Type 2 Diabetics. Iraqi Journal of Pharmaceutical Sciences 2017, 18 (Suppl.), 7-13. https://doi.org/10.31351/vol18issSuppl.pp7-13.